Laboratory Corporation of America Holdings Total Liabilities
Laboratory Corporation of America Holdings total liabilities. Based on the latest financial reports, Laboratory Corporation of America Holdings (LH) has total liabilities worth $10.34 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check LH asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Laboratory Corporation of America Holdings (1989–2025)
Total liabilities of Laboratory Corporation of America Holdings from 1989 to 2025. This chart illustrates how Laboratory Corporation of America Holdings's total liabilities have evolved over time, based on quarterly financial data. Explore LH long-term investments to assets to see how much of total assets are deployed in long-term investments.
Laboratory Corporation of America Holdings Competitors by Total Liabilities
The table below lists competitors of Laboratory Corporation of America Holdings ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bridgestone Corporation
F:BGTA
|
Germany | €2.03 Trillion |
|
VONOVIA SE ADR 1/2/O.N
F:VNAA
|
Germany | €60.17 Billion |
|
Grupo Carso S.A.B. de C.V
MX:GCARSOA1
|
Mexico | MX$95.27 Billion |
|
Credicorp Ltd
F:D8V
|
Germany | €228.27 Billion |
|
CMS Energy Corporation
NYSE:CMS
|
USA | $30.71 Billion |
|
Hua Nan Financial Holdings Co Ltd
TW:2880
|
Taiwan | NT$4.30 Trillion |
|
First Solar Inc
NASDAQ:FSLR
|
USA | $3.47 Billion |
|
EAST JP RAILW. ADR 1/6
F:EJR0
|
Germany | €7.30 Trillion |
Liability Composition Analysis (1989–2025)
This chart breaks down Laboratory Corporation of America Holdings's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Laboratory Corporation of America Holdin asset portfolio.
Liquidity & Leverage Metrics
Laboratory Corporation of America Holdings Total Liabilities Ratios Explained
Laboratory Corporation of America Holdings total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Laboratory Corporation of America Holdings's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Laboratory Corporation of America Holdings (1989–2025)
The table below shows the annual total liabilities of Laboratory Corporation of America Holdings from 1989 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $9.76 Billion | -5.40% |
| 2024-12-31 | $10.31 Billion | +16.73% |
| 2023-12-31 | $8.83 Billion | -12.00% |
| 2022-12-31 | $10.04 Billion | -0.51% |
| 2021-12-31 | $10.09 Billion | -4.93% |
| 2020-12-31 | $10.61 Billion | +1.48% |
| 2019-12-31 | $10.46 Billion | +13.75% |
| 2018-12-31 | $9.19 Billion | -6.63% |
| 2017-12-31 | $9.85 Billion | +12.86% |
| 2016-12-31 | $8.73 Billion | -4.58% |
| 2015-12-31 | $9.14 Billion | +104.87% |
| 2014-12-31 | $4.46 Billion | -0.11% |
| 2013-12-31 | $4.47 Billion | +10.14% |
| 2012-12-31 | $4.06 Billion | +11.23% |
| 2011-12-31 | $3.65 Billion | +2.66% |
| 2010-12-31 | $3.55 Billion | +36.07% |
| 2009-12-31 | $2.61 Billion | -8.70% |
| 2008-12-31 | $2.86 Billion | +8.21% |
| 2007-12-31 | $2.64 Billion | +30.60% |
| 2006-12-31 | $2.02 Billion | +1.69% |
| 2005-12-31 | $1.99 Billion | +22.33% |
| 2004-12-31 | $1.63 Billion | +7.10% |
| 2003-12-31 | $1.52 Billion | +56.81% |
| 2002-12-31 | $968.70 Million | +14.75% |
| 2001-12-31 | $844.20 Million | +6.93% |
| 2000-12-31 | $789.50 Million | -7.77% |
| 1999-12-31 | $856.00 Million | -10.81% |
| 1998-12-31 | $959.70 Million | -6.69% |
| 1997-12-31 | $1.03 Billion | -38.00% |
| 1996-12-31 | $1.66 Billion | +16.37% |
| 1995-12-31 | $1.43 Billion | +68.37% |
| 1994-12-31 | $846.70 Million | +90.40% |
| 1993-12-31 | $444.70 Million | +67.87% |
| 1992-12-31 | $264.90 Million | +229.07% |
| 1991-12-31 | $80.50 Million | -31.49% |
| 1990-12-31 | $117.50 Million | +207.59% |
| 1989-12-31 | $38.20 Million | -- |
About Laboratory Corporation of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcoh… Read more